Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients

BACKGROUND: There is no study accessible now assessing the prognostic aspect of radiomics for anti-PD-1 therapy for patients with HCC. AIM: The aim of this study was to develop and validate a radiomics nomogram by incorporating the pretreatment contrast-enhanced Computed tomography (CT) images and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Guosheng, Song, Yangda, Li, Qi, Hu, Xiaoyun, Zang, Mengya, Dai, Wencong, Cheng, Xiao, Huang, Wei, Yu, Wenxuan, Chen, Mian, Guo, Yabing, Zhang, Qifan, Chen, Jinzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820863/
https://www.ncbi.nlm.nih.gov/pubmed/33488622
http://dx.doi.org/10.3389/fimmu.2020.613946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820863/
https://www.ncbi.nlm.nih.gov/pubmed/33488622
http://dx.doi.org/10.3389/fimmu.2020.613946

Ejemplares similares